Translate this page into:
Incidental Finding of Lipomatous Hypertrophy of the Interatrial Septum during 18F-Fluorodeoxyglucose Positron Emission Tomography–Computed Tomography for Cervical Cancer
Address for correspondence: Dr. Alex Cheen Hoe Khoo, Department of Nuclear Medicine, Penang Adventist Hospital 465, Jalan Burma, George Town, 10350 Penang, Malaysia. E-mail: dr.alexkhoo@gmail.com
This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
This article was originally published by Medknow Publications & Media Pvt Ltd and was migrated to Scientific Scholar after the change of Publisher.
Abstract
Lipomatous hypertrophy of the interatrial septum is a benign but less recognized pathology of the heart caused by benign fatty infiltration of the interatrial septum which most often spares the fossa ovalis. We share images of the incidentally detected fluorodeoxyglucose (FDG) uptake in the interatrial septum during the restaging of 18F-FDG positron emission tomography/computed tomography scan of cervical cancer.
Keywords
18F-fluorodeoxyglucose
interatrial septum
lipomatous hypertrophy
positron emission tomography–computed tomography
The term lipomatous hypertrophy of the interatrial septum (LHIS) is actually a misnomer and is basically proliferation unencapsulated mature fat cell infiltrating the myocardial fibers of the interatrial septum. Therefore, it is neither hypertrophy of the fat cells nor a lipoma.[1] The incidence of LHIS detected on multislice computed tomography (CT) is reported to be 2.2%, whereas the incidence of LHIS detected through echocardiogram and autopsy has been reported between 1% and 8%.[23] We share images of incidentally detected fluorodeoxyglucose (FDG) uptake in the interatrial septum during restaging 18F-FDG positron emission tomography (PET)-CT scan of cervical cancer.
A 70-year-old hypertensive and diabetic woman was diagnosed with differentiated squamous cell carcinoma of the cervix in 2008. She had total abdominal hysterectomy with bilateral salphingo-oophorectomy followed by chemotherapy and local radiotherapy in 2009. She was apparently well until she was noted to have a solitary apicoposterior lung nodule measuring 8 mm on surveillance CT in late 2016. 18F-FDG PET-CT scan in February 2017 was performed 60-min postinjection of 370 megabecquerel (10 mCi) of 18F-FDG [Figure 1]. Although there is no definite value, most of the studies consider 20 mm as the defining thickness.[45] Thus, this case may reflect an early stage of the disease. The etiology of LHIS is unknown, but the presence of fetal brown fat amid the matured fat cells contributes to the FDG uptake frequently seen in this condition.[5] This condition occurs predominantly in the elderly, obese female and with metabolic disorders.[4] The importance of this benign and less often recognized pathology is that there is increased incidence of atrial arrhythmias and sudden cardiac death. Fortunately, this woman did not have any cardiac arrhythmias to date and is currently also being monitored by cardiologists. Recognizing LHIS is important to avoid misdiagnosis of cardiac metastases which may lead to unnecessary cardiac surgery or given suboptimal treatment.[56]

Declaration of patient consent
The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
Acknowledgment
The authors would like to thank the Director-General of Health Malaysia for the permission to publish this paper.
References
- Lipomatous hypertrophy of the interatrial septum: An overview. Arch Pathol Lab Med. 2006;130:397-9.
- [Google Scholar]
- Lipomatous hypertrophy of the interatrial septum: A prospective study of incidence, imaging findings, and clinical symptoms. Chest. 2003;124:2068-73.
- [Google Scholar]
- Lipomatous hypertrophy of the cardiac interatrial septum: A report of 38 cases and review of the literature. Am J Clin Pathol. 1979;72:785-8.
- [Google Scholar]
- Lipomatous hypertrophy of the interatrial septum: A pathological and clinical approach. Int J Cardiol. 2007;121:4-8.
- [Google Scholar]
- Lipomatous hypertrophy of the interatrial septum: Increased uptake on FDG PET. AJR Am J Roentgenol. 2005;184:339-42.
- [Google Scholar]
- Lipomatous hypertrophy of the interatrial septum: A commonly misdiagnosed mass often leading to unnecessary cardiac surgery. Heart. 2004;90:e66.
- [Google Scholar]
